Heart failure with preserved ejection fraction (HFpEF)

被引:4
|
作者
Maeder, Micha T. [1 ]
Buser, Marc [1 ]
Brenner, Roman [1 ]
Rickli, Hans [1 ]
机构
[1] Kantonsspital St Gallen, Klin Kardiol, Rorschacherstr 95, CH-9007 St Gallen, Switzerland
关键词
D O I
10.1024/0040-5930/a000983
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure with preserved left ventricular ejection fraction (HFpEF) is a very common form of heart failure typically seen in older patients and associated with poor prognosis. Patients with HFpEF are characterized by a s small left ventricle with concentric remodeling and abnormal compliance, which under the impact of additional cardiovascular mechanisms and non-cardiac comorbidities, leads to the cardinal symptoms of dyspnea and exercise intolerance. The diagnosis of HFpEF is still under debate, and the therapeutic options are limited despite intensive research efforts. In the present review article, we provide an overview of the current understanding of the pathiohysiology of HFpEF, the current diagnostic approach, and a summary of the available evidence on treatment.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 50 条
  • [41] Evaluation of Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction (HFpEF) -Is It Possible to Delineate the Phenotype of HFpEF? -
    Izumi, Chisato
    CIRCULATION JOURNAL, 2022, 86 (01) : 34 - 36
  • [42] IMPACT OF STATINS ON LONG TERM MORTALITY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
    Lahoti, Ankush
    Saeed, Wajeeha
    Badri, Marwan
    Gnall, Eric
    Sardar, Rizwan
    Zolty, Ronald
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1010 - E1010
  • [43] Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review
    Hannah Clark
    Rezwanul Rana
    Jeff Gow
    Melissa Pearson
    Tom van der Touw
    Neil Smart
    Heart Failure Reviews, 2022, 27 : 559 - 572
  • [44] FEATURES OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) IN DIABETIC PATIENTS WITH RESISTANT HYPERTENSION
    Manukyan, Musheg A.
    Falkovskaya, Alla Yu
    Mordovin, Victor F.
    Ryabova, Tamara R.
    Zyubanova, Irina, V
    Gusakova, Anna M.
    Suslova, Tatyana E.
    DIABETES MELLITUS, 2021, 24 (04): : 304 - 314
  • [45] Patterns of heart failure with preserved ejection (HFpEF) fraction in diabetics from southeast asia
    Rizwal, I. Johan
    Othman, I. Zubin
    Kamal, M. A. Mohd
    Effarezan, A. R.
    Aiza, Z. A. Hafisyatul
    Lim, C. W.
    Najme, K. Rizmy
    Nicholas, C. Y. C.
    Kasim, S.
    Yusoff, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 364 - 364
  • [46] Therapeutic Approaches in Heart Failure with Preserved Ejection Fraction (HFpEF) in Children: Present and Future
    Bibhuti B. Das
    Pediatric Drugs, 2022, 24 : 235 - 246
  • [47] Prognostic Significance of Tubular Injury Biomarkers in Heart Failure With Preserved Ejection Fraction (HFpEF)
    Salman, Oday
    Qian, Chenao
    Cohen, Jordana
    Jehangir, Qasim
    Zamani, Payman
    Ebert, Christina
    Greenawalt, Danielle
    Wang, Zhaoqing
    Zhao, Lei
    Chang, Ching-Pin
    Gordon, David A.
    Ramirez-Valle, Francisco
    Cappola, Thomas P.
    Chirinos, Julio A.
    CIRCULATION, 2022, 146
  • [48] Ketone-based metabolism and signalling in heart failure with preserved ejection fraction (HFpEF)
    Wang, R.
    Capone, F.
    Luo, L.
    Keller, D.
    Jung, S.
    Pauline, F.
    Mertins, P.
    Sotomayor-Flores, C.
    Bode, D.
    Grunert, N.
    Schiattarella, G.
    CARDIOVASCULAR RESEARCH, 2024, 120
  • [49] Impact of Severe Obesity on Exercise Performance in Heart Failure With Preserved Ejection Fraction (HFpEF)
    Sarma, Satyam
    Hieda, Michinari
    Hearon, Christopher
    Livingston, Sheryl
    Everding, Braden
    Samels, Mitchel
    Palmer, Michael D.
    Levine, Benjamin D.
    CIRCULATION, 2017, 136
  • [50] The dawn of a new era of targeted therapies for heart failure with preserved ejection fraction (HFpEF)
    Kenji Harada
    Kazuomi Kario
    Hypertension Research, 2022, 45 : 164 - 166